
Teladoc Health Expands Comprehensive Weight Care Program With Employer Contributions for GLP-1 Medications
Teladoc Health, a global provider of virtual healthcare services, has announced an expansion of its Comprehensive Weight Care program, introducing a new employer contribution option designed to improve access to FDA-approved GLP-1 medications and comprehensive obesity care. The expanded offering gives employers greater flexibility in supporting employees and their families while providing more predictable and transparent management of medication-related healthcare expenses.
Through the new option, employers can contribute toward the cost of GLP-1 medications outside traditional pharmacy benefit structures. The program allows organizations to establish flexible employee out-of-pocket costs while providing access to authentic, FDA-approved medications from Eli Lilly and Company and Novo.
The expanded program combines medication access with clinical care, nutritional guidance, lifestyle support and ongoing engagement. Teladoc Health aims to help employers address growing demand for obesity treatment while providing employees with a structured healthcare program that supports long-term weight management.
The announcement comes as interest in GLP-1 medications continues to grow across the United States. Although these medications have become an important option in obesity management, insurance coverage and affordability remain significant challenges for many individuals.
According to a healthcare survey conducted by WTW, nearly half of employers currently do not cover GLP-1 medications for weight loss. This coverage gap creates challenges for employees seeking medically supervised obesity treatment and for employers looking for ways to provide competitive healthcare benefits without facing unpredictable spending.
Teladoc Health’s expanded offering is designed to address this challenge by creating another approach to employer-funded access. Rather than relying exclusively on conventional pharmacy benefit designs, organizations can establish a fixed contribution toward eligible medication fills while allowing employees to pay the remaining balance.
The initiative reflects Teladoc Health’s broader strategy to strengthen its virtual care services and provide employers with integrated healthcare solutions that combine medication access, clinical expertise and digital health support.
Expanding Employer Access to FDA-Approved GLP-1 Medications
A central feature of the expanded Comprehensive Weight Care program is the ability for employers to contribute directly toward the cost of GLP-1 medications.
GLP-1 medications have attracted significant attention because of their role in managing obesity and supporting metabolic health. These treatments can help regulate appetite and food intake and are used as part of medical weight management for eligible patients.
However, the cost of treatment and differences in insurance coverage can make access difficult. Some employers have chosen not to include weight-loss medications in their traditional pharmacy benefits because of concerns about affordability and long-term healthcare spending.
Teladoc Health’s new employer contribution option provides an alternative structure. Organizations can decide how much financial support they want to offer for each medication fill, creating an opportunity to provide access while maintaining greater control over their benefit budgets.
The program includes access to authentic, FDA-approved medications from Eli Lilly and Company and Novo. Employees and their families can also receive comprehensive clinical support throughout their weight management journey.
Kelly Bliss, President of U.S. Group Health at Teladoc Health, said employers are looking for flexible healthcare benefit strategies that help employees achieve their health goals while allowing organizations to manage healthcare expenses more effectively.
Bliss explained that the expanded program is intended to meet workforce healthcare needs while providing greater transparency and predictability around spending.
She also emphasized the importance of giving individuals a trusted pathway to high-quality medical care and affordable access to FDA-approved medications, supported by services designed to encourage meaningful and sustained health outcomes.
Collaboration With Lilly and Novo to Improve Medication Access
The expanded offering includes access pathways involving two major pharmaceutical companies, Eli Lilly and Company and Novo.
The collaboration is intended to provide employers with additional flexibility in supporting employees who need obesity care while maintaining a clear structure for managing medication-related expenses.
Kevin Hern, Senior Vice President of Lilly Employer at Lilly USA, highlighted the continuing challenges associated with access to obesity treatment.
Hern noted that many people still lack adequate coverage for obesity care and explained that Lilly is working to address this access gap.
Through Lilly Employer Connect, employers can gain greater choice, control and cost transparency when developing programs that support access to obesity medications. The arrangement is intended to help organizations determine how they want to contribute toward employee treatment costs.
Lilly welcomed Teladoc Health’s role in bringing additional flexibility to employer healthcare programs.
Tom Scales, Senior Vice President of Market Access and Public Affairs for Novo, also emphasized the importance of developing access models that work for both patients and employers.
According to Scales, expanding access to obesity care requires approaches that address affordability while giving employers a clear understanding of their financial responsibilities.
Novo works with approved collaborators, including Teladoc Health, to provide employer-funded access pathways. These arrangements are designed to help organizations manage medication costs more predictably while supporting employees seeking obesity treatment.
The involvement of Lilly and Novo strengthens the medication access component of the expanded program and provides employers with additional options when designing weight management benefits.
Comprehensive Clinical and Lifestyle Support Beyond Medication
While medication access is an important part of the expanded program, Teladoc Health is positioning Comprehensive Weight Care as a broader healthcare service rather than a medication-only benefit.
The program combines access to GLP-1 medications with multidisciplinary support from licensed obesity medicine clinicians, registered dietitians and health coaches. This approach is intended to help members address the medical, nutritional and behavioral factors associated with weight management.
Members can access several services and digital tools designed to support their progress, including:
- Licensed obesity medicine clinicians: Medical professionals who provide clinical assessments, treatment guidance and ongoing support throughout the weight management process.
- Registered dietitians: Nutrition specialists who help members develop personalized eating plans and make healthier food choices.
- Health coaches: Professionals who support lifestyle changes, encourage consistent participation and help members work toward their health goals.
- Connected digital scales: Technology that allows members to monitor their weight and track progress over time.
- Personalized lifestyle coaching: Guidance designed to help individuals establish sustainable habits related to physical activity, nutrition and overall wellness.
- Nutrition counseling: Individualized support to help members understand their dietary requirements and make informed decisions about food.
- AI-enabled food logging: Digital capabilities that help members record and monitor their food intake through the Teladoc Health application.
- Mental health support: Resources that recognize the relationship between emotional well-being, behavior and long-term health management.
- Behavior-change resources: Educational materials and tools intended to encourage healthy routines and sustained participation.
The multidisciplinary care model is designed to provide continuous support rather than limiting the relationship between patients and healthcare professionals to occasional consultations.
The care team remains involved over time, helping members navigate their treatment journey, monitor progress and make adjustments when necessary.
This ongoing engagement is particularly important in obesity management, where long-term results may depend on consistent lifestyle changes, appropriate medical treatment and regular follow-up.
By combining clinical expertise with digital health tools, Teladoc Health aims to create a more connected experience for employees and their families.
How the New Employer Contribution Model Works
The expanded program introduces a structured payment arrangement that allows employers to support medication costs while maintaining greater visibility into their healthcare spending.
Under the new model, employers can manage both the clinical weight management program and medication access through a single contract with Teladoc Health.
This arrangement is intended to simplify administration by bringing different components of the benefit together under one program.
At the beginning of each plan year, an employer determines a fixed contribution amount per employee per medication fill. The contribution applies consistently across covered medications.
Employees are responsible for paying the remaining balance for each medication fill after the employer contribution has been applied.
This structure allows organizations to establish their financial commitment in advance rather than relying entirely on traditional pharmacy benefit arrangements.
For example, employers can determine the amount they are willing to contribute toward each eligible medication fill based on their workforce benefit strategy and available healthcare budget. The employee’s remaining payment is calculated after applying that contribution.
The model is designed to provide greater clarity around the financial responsibilities of both employers and employees.
Teladoc Health will manage several administrative components of the program, including eligibility verification, program oversight and consolidated employer invoicing.
The company will also coordinate medication claims administration through a 100% pass-through model.
Under this arrangement, pharmacy claims are administered with eligibility verification, real-time application of the employer’s contribution and documentation designed to support auditing requirements.
This approach is intended to give employers a clearer understanding of how medication-related expenses are processed.
Greater Cost Transparency and Predictable Healthcare Spending
One of the major objectives of the new employer contribution option is to address concerns about unpredictable medication spending.
GLP-1 medications have become an important consideration in employer healthcare planning because of growing employee interest and the financial implications of providing coverage.
Organizations need to balance employee demand for effective healthcare benefits with the responsibility of managing annual healthcare budgets.
Teladoc Health’s expanded model is designed to provide more detailed information about medication expenses.
Employers will receive visibility into the costs associated with each medication fill, including:
- The cost of the medication.
- The pharmacy dispensing fee.
- The claims administration fee.
By separating these components, the program gives benefits teams a clearer picture of what they are paying for and how the total expense is calculated.
Employers can use this information to determine an appropriate contribution level and estimate potential program spending for the year.
The fixed contribution structure also provides organizations with a defined financial commitment for each eligible fill.
Teladoc Health believes this transparency can help employers make more informed decisions when designing healthcare benefits and evaluating the affordability of obesity treatment programs.
For employees, the arrangement creates another potential pathway to access FDA-approved medications while receiving support from a comprehensive weight management program.
Employers Can Link Contributions to Program Engagement
Another feature of the expanded offering is the flexibility to connect employer contributions with employee participation in the weight management program.
Employers can choose to establish engagement-related criteria that determine eligibility for their financial contribution toward medication costs.
These criteria may include activities such as regular food logging, consistent weigh-ins, engagement with educational content and ongoing participation in the program.
This option allows employers to encourage employees to remain actively involved in their weight management journey.
The approach also reflects the importance of combining medication with broader lifestyle support.
For example, regular food logging can help members become more aware of their nutritional habits, while consistent weight monitoring can provide information about progress over time.
Engagement with educational resources can help individuals understand the factors that influence weight management and develop healthier routines.
The company aims to give employers flexibility in determining how these participation requirements fit into their overall healthcare benefit strategy.
By connecting financial support with program engagement, organizations may encourage employees to make greater use of the clinical and lifestyle resources available through Comprehensive Weight Care.
The program therefore combines medication affordability with an emphasis on sustained participation and healthier behavior.
New Research Highlights Long-Term Weight Loss Outcomes
Alongside announcing the expanded employer contribution option, Teladoc Health has released new research examining weight management outcomes over a two-year period.
The research analyzed nearly 23,000 members enrolled in the company’s Weight and Diabetes Prevention programs. It examined weight-loss progress over 24 months and highlighted the potential importance of sustained participation and continued access to comprehensive lifestyle support.
The findings suggest that clinically meaningful weight loss can continue beyond the first year when individuals remain engaged in structured weight management programs.
According to the research:
- 47.7% achieved at least 5% weight loss: Nearly half of the members included in the analysis achieved a weight reduction of at least 5% by the 24-month mark.
- 53% continued losing weight during the second year: Among members who had already lost weight during their first year, more than half continued to lose additional weight in year two.
- Nearly one-third achieved 10% or greater weight loss: The research found that almost one-third of participating members reached a weight reduction of at least 10% over 24 months.
- Average BMI declined by 2.3 points: Members experienced an average reduction of 2.3 points in body mass index during the two-year period.
- Improvements in BMI categories: Approximately one in five members moved from an obesity category into either the overweight or healthy BMI range.
These findings highlight the potential value of maintaining access to weight management support over an extended period.
Weight management is often a long-term process that requires consistent attention to nutrition, physical activity, behavioral patterns and medical needs. While some individuals may achieve initial progress, maintaining that progress can require continued guidance and support.
Teladoc Health’s research suggests that participation in structured programs over time may help members continue making progress beyond their first year.
The findings also reinforce the company’s approach of combining clinical care, lifestyle coaching and digital engagement rather than focusing exclusively on medication access.
However, the reported results relate to members enrolled in the company’s Weight and Diabetes Prevention programs and should not be interpreted as guaranteed outcomes for every participant or as evidence that medication alone produced the observed weight loss.
Additional Research Examines GLP-1 Utilization Patterns
Teladoc Health also highlighted additional research presented at ObesityWeek 2026 in Washington, D.C.
This research focused on GLP-1 medication utilization patterns and their association with weight loss at 12 months and the durability of weight-loss outcomes at 24 months.
The research reflects growing interest in understanding how GLP-1 medications are used over time and how treatment patterns may relate to longer-term weight management results.
As the use of these medications expands, healthcare organizations are increasingly examining questions related to treatment continuity, patient engagement and the importance of ongoing lifestyle support.
Medication access is one part of obesity treatment, but long-term management also involves clinical monitoring, nutritional guidance and behavioral interventions.
By examining medication utilization alongside weight-loss outcomes, Teladoc Health aims to contribute additional insights into how comprehensive weight management programs can support individuals over extended periods.
The research also complements the company’s broader strategy of integrating virtual clinical services with digital health technologies and personalized lifestyle interventions.
Building on Teladoc Health’s Existing GLP-1 Services
The new employer contribution option is part of Teladoc Health’s continuing efforts to expand its integrated care offerings and provide additional value to healthcare customers.
The company previously introduced a GLP-1 medication self-pay option within its Comprehensive Weight Care program.
That offering provided another pathway for individuals seeking access to GLP-1 medications outside conventional insurance coverage arrangements.
The latest expansion builds on this approach by introducing an employer-funded contribution model.
Through the new arrangement, organizations can support medication costs while employees receive access to clinical services and lifestyle resources.
Teladoc Health is also continuing to develop its Teladoc One care model, which is designed to bring different virtual healthcare services together through a more connected approach.
The broader strategy focuses on integrating medical care, digital health capabilities and personalized support to address multiple healthcare needs.
The expanded Comprehensive Weight Care program fits within this direction by combining obesity treatment, medication access, nutrition services and behavioral support through a coordinated virtual care experience.
For employers, this creates an opportunity to offer a more comprehensive weight management benefit without relying exclusively on traditional pharmacy coverage structures.
For employees, the program aims to provide a more accessible and coordinated pathway to medically supervised weight care.
Employer Contribution Option Available Ahead of 2027 Launches
Teladoc Health’s new employer contribution option is available now, allowing organizations to begin evaluating the offering and establishing their program arrangements.
The first contracted employer clients are expected to launch their programs for employees on January 1, 2027.
This timeline provides organizations with an opportunity to incorporate the expanded benefit into their upcoming healthcare planning and employee benefits strategies.
As employers continue evaluating the financial implications of GLP-1 coverage, flexible contribution models may become an important consideration in designing healthcare programs.
Teladoc Health’s approach is intended to give organizations greater control over their financial commitments while maintaining access to FDA-approved medication options and comprehensive clinical support.
The company is positioning the expanded program as a solution that addresses several challenges at the same time: medication affordability, employee demand, long-term weight management and healthcare spending transparency.
Advancing Virtual Obesity Care Through Integrated Healthcare Solutions
The expansion of Comprehensive Weight Care highlights Teladoc Health’s efforts to strengthen its position in virtual healthcare and address the growing demand for medically supervised obesity treatment.
By combining employer contributions toward GLP-1 medications with clinical expertise, nutrition counseling, health coaching, digital monitoring and behavioral support, the company aims to provide a more complete approach to weight management.
The introduction of the new payment structure also gives employers an additional option for supporting employees who may otherwise face difficulties accessing obesity medications because of coverage limitations.
The two-year research findings further emphasize the importance of continued participation and comprehensive lifestyle support in achieving meaningful weight management progress.
With the first employer programs scheduled to begin on January 1, 2027, Teladoc Health is expanding its efforts to connect medication access with long-term clinical care.
As obesity management continues to receive attention across the healthcare industry, the company’s expanded offering represents another development in employer-sponsored virtual care, combining financial flexibility with personalized medical and lifestyle services.
Through this initiative, Teladoc Health aims to help employers support workforce health goals, improve access to obesity care and provide employees and their families with additional resources for managing weight and metabolic health over time.
Source link: https://www.teladochealth.com/





